Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-GITR antibodies and uses thereof

Anti-GITR antibodies and uses thereof

US Patent 11414494 · Granted Aug 16, 2022

Estimated economic value: $438,424,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
EGFR x CD28 multispecific antibodies2025
Glypican-3 (GPC-3) antibodies2025
Therapeutic uses of anti-GITR antibodies2025
Therapeutic uses of anti-GITR antibodies2025
Pyrazole derivatives and use thereof2025
Multispecific antigen-binding molecules and uses thereof2025
Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies2025
Chimeric antigen receptors with BCMA specificity and uses thereof2024
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use ther2024
Bispecific antigen binding molecules that bind HER2, and methods of use thereof2024
EGFR × CD28 multispecific antibodies2024